Desmocollin 3 (DSC3) was found to be frequently down-regulated in several cancers such as breast, oral, colorectal and lung cancer, and inactivation of DSC3 in these cancers was caused by promoter hypermethylation[13], [14], [15], [24]. This evidence concerns the gene DSC3 and lung cancer.